Cargando…

Chronic Enterovirus Meningoencephalitis in Prolonged B-Cell Depletion After Rituximab Therapy: Case Report

OBJECTIVES: Persistent impaired immunity is possible even years after B-cell depleting therapies. This may favor the occurrence of infections, including infectious meningitis and encephalitis. In this study, we report a case of chronic enterovirus meningoencephalitis in prolonged B-cell depletion ye...

Descripción completa

Detalles Bibliográficos
Autores principales: Jacksch, Clemens, Dargvainiene, Justina, Böttcher, Sindy, Diedrich, Sabine, Leypoldt, Frank, Stürner, Klarissa, Berg, Daniela, Schäffer, Eva
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10574820/
https://www.ncbi.nlm.nih.gov/pubmed/37813597
http://dx.doi.org/10.1212/NXI.0000000000200171
_version_ 1785120779075059712
author Jacksch, Clemens
Dargvainiene, Justina
Böttcher, Sindy
Diedrich, Sabine
Leypoldt, Frank
Stürner, Klarissa
Berg, Daniela
Schäffer, Eva
author_facet Jacksch, Clemens
Dargvainiene, Justina
Böttcher, Sindy
Diedrich, Sabine
Leypoldt, Frank
Stürner, Klarissa
Berg, Daniela
Schäffer, Eva
author_sort Jacksch, Clemens
collection PubMed
description OBJECTIVES: Persistent impaired immunity is possible even years after B-cell depleting therapies. This may favor the occurrence of infections, including infectious meningitis and encephalitis. In this study, we report a case of chronic enterovirus meningoencephalitis in prolonged B-cell depletion years after rituximab therapy. METHODS: This is a case report from a German academic hospital. In addition to repeated clinical examinations, repeated brain MRI and extended CSF and laboratory diagnostics were performed. We used the CARE checklist when writing our report. RESULTS: A 38-year-old man presented with high fever (>40°C), severe headache, and progressive neurologic and cognitive deficits. As result of previous lymphoma therapy with rituximab years ago, prolonged B-cell aplasia was detected. To restore humoral immunity, the patient received repeated infusions of immunoglobulins. In the end, a complete restitution of the physical and mental condition was achieved with the established therapy. DISCUSSION: This case report should emphasize the importance of assessing humoral immunity even years after B-cell depletion therapy, especially in case of opportunistic infections.
format Online
Article
Text
id pubmed-10574820
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-105748202023-10-14 Chronic Enterovirus Meningoencephalitis in Prolonged B-Cell Depletion After Rituximab Therapy: Case Report Jacksch, Clemens Dargvainiene, Justina Böttcher, Sindy Diedrich, Sabine Leypoldt, Frank Stürner, Klarissa Berg, Daniela Schäffer, Eva Neurol Neuroimmunol Neuroinflamm Research Article OBJECTIVES: Persistent impaired immunity is possible even years after B-cell depleting therapies. This may favor the occurrence of infections, including infectious meningitis and encephalitis. In this study, we report a case of chronic enterovirus meningoencephalitis in prolonged B-cell depletion years after rituximab therapy. METHODS: This is a case report from a German academic hospital. In addition to repeated clinical examinations, repeated brain MRI and extended CSF and laboratory diagnostics were performed. We used the CARE checklist when writing our report. RESULTS: A 38-year-old man presented with high fever (>40°C), severe headache, and progressive neurologic and cognitive deficits. As result of previous lymphoma therapy with rituximab years ago, prolonged B-cell aplasia was detected. To restore humoral immunity, the patient received repeated infusions of immunoglobulins. In the end, a complete restitution of the physical and mental condition was achieved with the established therapy. DISCUSSION: This case report should emphasize the importance of assessing humoral immunity even years after B-cell depletion therapy, especially in case of opportunistic infections. Lippincott Williams & Wilkins 2023-10-09 /pmc/articles/PMC10574820/ /pubmed/37813597 http://dx.doi.org/10.1212/NXI.0000000000200171 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License 4.0 (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) , which permits downloading and sharing the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.
spellingShingle Research Article
Jacksch, Clemens
Dargvainiene, Justina
Böttcher, Sindy
Diedrich, Sabine
Leypoldt, Frank
Stürner, Klarissa
Berg, Daniela
Schäffer, Eva
Chronic Enterovirus Meningoencephalitis in Prolonged B-Cell Depletion After Rituximab Therapy: Case Report
title Chronic Enterovirus Meningoencephalitis in Prolonged B-Cell Depletion After Rituximab Therapy: Case Report
title_full Chronic Enterovirus Meningoencephalitis in Prolonged B-Cell Depletion After Rituximab Therapy: Case Report
title_fullStr Chronic Enterovirus Meningoencephalitis in Prolonged B-Cell Depletion After Rituximab Therapy: Case Report
title_full_unstemmed Chronic Enterovirus Meningoencephalitis in Prolonged B-Cell Depletion After Rituximab Therapy: Case Report
title_short Chronic Enterovirus Meningoencephalitis in Prolonged B-Cell Depletion After Rituximab Therapy: Case Report
title_sort chronic enterovirus meningoencephalitis in prolonged b-cell depletion after rituximab therapy: case report
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10574820/
https://www.ncbi.nlm.nih.gov/pubmed/37813597
http://dx.doi.org/10.1212/NXI.0000000000200171
work_keys_str_mv AT jackschclemens chronicenterovirusmeningoencephalitisinprolongedbcelldepletionafterrituximabtherapycasereport
AT dargvainienejustina chronicenterovirusmeningoencephalitisinprolongedbcelldepletionafterrituximabtherapycasereport
AT bottchersindy chronicenterovirusmeningoencephalitisinprolongedbcelldepletionafterrituximabtherapycasereport
AT diedrichsabine chronicenterovirusmeningoencephalitisinprolongedbcelldepletionafterrituximabtherapycasereport
AT leypoldtfrank chronicenterovirusmeningoencephalitisinprolongedbcelldepletionafterrituximabtherapycasereport
AT sturnerklarissa chronicenterovirusmeningoencephalitisinprolongedbcelldepletionafterrituximabtherapycasereport
AT bergdaniela chronicenterovirusmeningoencephalitisinprolongedbcelldepletionafterrituximabtherapycasereport
AT schaffereva chronicenterovirusmeningoencephalitisinprolongedbcelldepletionafterrituximabtherapycasereport